Innovation is not dead in DMPK: New platforms that deliver the future for pharma

This is the final presentation in a brand new series of 4 webinars brought to you by Bioanalysis and Waters Corporation on ‘Opportunities in a Changing Landscape: Innovative LC/MS Solutions that will Usher in the Future of DMPK.’

In this webinar Mark Wrona, Principal Applications Chemist at Waters discussed ‘Innovation is not dead in DMPK – New platforms that deliver the future for Pharma’ and Joanne Mather, Senior Scientist, Pharmaceutical and Life Sciences, at Waters discussed ‘Comprehensive workflows for selective and sensitive bioanalytical methods of biotherapeutics’

We hope you enjoy this presentation and if you have any questions for the speakers or host please do contact us by emailing [email protected].

Other webinars in this series include:

• The Analysis of Teriparatide by LC-MS/MS – The Challenges and Lessons Learned presented by Elizabeth Thomas, Vice President and General Manager UK Bioanalytical Operations at ICON.

• The Shining Future of Accurate Mass Quantitation for Small and Large Molecules presented by Chris Evans, Pharmaceuticals Director at GlaxoSmithKline

• Protein and Peptide Therapeutics: Addressing bioanalytical demands of complicated peptides presented by Erin Chambers, Principal Applications Chemist at Waters